Does limited expression of toll-like receptor 9 actually contribute to T cell activation and liver damage in nonalcoholic steatohepatitis?
Clinical and Molecular Hepatology. 2020;26(2):236-237 
Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice
Hepatology. 2013;57(2):577-589
Limited expression of toll-like receptor 9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
Clinical and Molecular Hepatology. 2020;26(2):240-241
Activation of the endotoxin/toll-like receptor 4 pathway: The way to go from nonalcoholic steatohepatitis up to hepatocellular carcinoma
Hepatology. 2010;53(3):1069-1069
Hepatocyte mitochondrial DNA released in microparticles and toll‐like receptor 9 activation: A link between lipotoxicity and inflammation during nonalcoholic steatohepatitis
Hepatology. 2016;64(2):669-671
Enhanced Expression of Toll-Like Receptor 4 and MyD88 is Associated With Disease Progression in Human Nonalcoholic Fatty Liver Disease
Gastroenterology. 2011;140(5):S-978
Toll-Like Receptor 4 Activation by Damage-Associated Molecular Patterns (DAMPs)
Progress in Inflammation Research. 2020;93-103
Mechanism regulating cell surface expression and activation of Toll-like receptor 4
The Chemical Record. 2006;6(6):311-319
Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
Metabolites. 2021;11(2):73
Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8
Digestive Diseases and Sciences. 2010;56(5):1524-1534